BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16171525)

  • 1. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?
    Gur A; Dikici B; Nas K; Bosnak M; Haspolat K; Sarac AJ
    BMC Gastroenterol; 2005 Sep; 5():30. PubMed ID: 16171525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary results of interferon alpha-2a and lamivudine combination therapy regimen in children with chronic hepatitis B].
    Aşik Akman S; Cokçeken Okçu S; Anil OH; Köse S; Bakiler AR
    Mikrobiyol Bul; 2006; 40(1-2):47-53. PubMed ID: 16775956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of hepatitis B vaccination and interferon-alpha-2b combination therapy versus interferon-alpha-2b monotherapy in children with chronic hepatitis B.
    Helvaci M; Kizilgunesler A; Kasirga E; Ozbal E; Kuzu M; Sozen G
    J Gastroenterol Hepatol; 2004 Jul; 19(7):785-91. PubMed ID: 15209626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antiviral effect of lamivudine with interferon-alpha2a versus -alpha2b in children with chronic hepatitis B infection.
    Ozgenc F; Dikici B; Targan S; Doganci T; Akman S; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Feb; 9(1):23-6. PubMed ID: 15040533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy.
    Hofmann WP; Kronenberger B; Bojunga J; Stamm B; Herrmann E; Bücker A; Mihm U; von Wagner M; Zeuzem S; Sarrazin C
    J Viral Hepat; 2008 Nov; 15(11):790-6. PubMed ID: 18673425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women.
    Marques EA; Mota J; Viana JL; Tuna D; Figueiredo P; Guimarães JT; Carvalho J
    Arch Gerontol Geriatr; 2013; 57(2):226-33. PubMed ID: 23623588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.
    Akman SA; Okcu SC; Halicioğlu O; Sutcuoglu S; Anil M; Kizilgunesler A; Bakiler AR
    Pediatr Int; 2007 Dec; 49(6):848-52. PubMed ID: 18045284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamivudine treatment for children with interferon refractory chronic hepatitis B.
    Koçak N; Saltik IN; Ozen H; Yüce ; Gürakan F
    Hepatology; 2000 Feb; 31(2):545. PubMed ID: 10691379
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical observation of serum IL-18, IL-10 and sIL-2R levels in patients with chronic hepatitis C pre- and post antiviral treatment.
    Jia H; Du J; Zhu S; Ma Y; Cai H
    Chin Med J (Engl); 2003 Apr; 116(4):605-8. PubMed ID: 12875732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
    ter Borg MJ; Hansen BE; Herrmann E; Zeuzem S; Cakaloglu Y; Karayalcin S; Flisiak R; van' t Veen A; de Man RA; Schalm SW; Janssen HL; Haagmans BL;
    Antivir Ther; 2007; 12(8):1285-94. PubMed ID: 18240868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Hadziyannis SJ
    Aliment Pharmacol Ther; 2006 Jan; 23(1):99-106. PubMed ID: 16393286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of interferon alpha-2b and lamivudine therapy for chronic hepatitis B in children.
    Bahar A; Iscan S; Karademir F; Gocmen I
    Chin Med J (Engl); 2003 Apr; 116(4):593-6. PubMed ID: 12875729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate.
    Rittmaster RS; Bolognese M; Ettinger MP; Hanley DA; Hodsman AB; Kendler DL; Rosen CJ
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2129-34. PubMed ID: 10852440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium supplementation increases bone mass in GH-deficient prepubertal children during GH replacement.
    Zamboni G; Antoniazzi F; Lauriola S; Bertoldo F; Tatò L
    Horm Res; 2006; 65(5):223-30. PubMed ID: 16569932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.
    van Zonneveld M; Zondervan PE; Cakaloglu Y; Simon C; Akarca US; So TM; Flink HJ; de Man RA; Schalm SW; Janssen HL;
    Liver Int; 2006 May; 26(4):399-405. PubMed ID: 16629642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.